Yamana Gold Declares Second Quarter Dividend

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Yamana Gold Declares Second Quarter Dividend

TORONTO, ONTARIO--(Marketwired - April 28, 2015) - YAMANA GOLD INC. (TSX:YRI)(NYSE:AUY) ("Yamana" or the "Company") declares a second quarter 2015 dividend of $0.015 per share. Shareholders of record at the close of business on June 30, 2015 will be entitled to receive payment of this dividend on July 14, 2015. The dividend is an "eligible dividend" for Canadian tax purposes.

The Company provides shareholders with the option to participate in a Dividend Reinvestment Plan ("DRIP"). Participants in the DRIP may obtain additional common shares of the Company by automatically reinvesting all or any portion of the cash dividends paid on common shares held by the DRIP participant without paying any brokerage commissions, administrative costs or other service charges. The enrollment forms are available on the Company's website at www.yamana.com and under Yamana's profile on CST's website at www.canstockta.com . All shareholders considering enrollment in the DRIP should carefully review the terms of the DRIP and consult with their advisors as to the implications of enrollment in the DRIP.

(All amounts are expressed in United States dollars unless otherwise indicated.)

About Yamana

Yamana is a Canadian-based gold producer with significant gold production, gold development stage properties, exploration properties, and land positions throughout the Americas including Brazil, Argentina, Chile, Mexico and Canada. Yamana plans to continue to build on this base through existing operating mine expansions, throughput increases, development of new mines, the advancement of its exploration properties and by targeting other gold consolidation opportunities with a primary focus in the Americas.

Yamana Gold Inc. Lisa Doddridge, Vice President, Corporate Communications and Investor Relations 416-815-0220 or 1-888-809-0925 investor@yamana.com
Scroll down for more posts ▼

Top 10 Most Recent News Articles

2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 34

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 44

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 41

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 39

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 36

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 31

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading

Top 5 Most Recently Viewed Articles

KPN Achieves Impressive Growth; Forecast for 2025 Enhanced

Updated Category News Views 271

KPN Achieves Remarkable Growth in Q2 2025 KPN has recently demonstrated a strong performance in the second quarter of 2025, showcasing impressive growth across various segments. The company reported a year-on-year growth of 3.7% in service revenues, a testament to its robust business strategy and market position. Consumer Service Revenue Gains The consumer segment has...

Continue Reading
Socket Mobile's Financial Trends Show Promise for Future Growth

Updated Category News Views 66

Socket Mobile Reports Q3 Financial Results Socket Mobile, Inc. (NASDAQ: SCKT), a prominent name in the field of data capture and delivery solutions, recently disclosed its financial results for the third quarter of 2024, presenting notable shifts in revenue and product adoption. The company emphasizes its commitment to enhancing productivity through innovative...

Continue Reading
Sapiens Recognized for Outstanding Software Solutions Excellence

Updated Category News Views 220

Sapiens UnderwritingPro Achieves Recognition for Excellence Sapiens International Corporation has once again made waves in the insurance industry with its advanced UnderwritingPro solution. Renowned for driving efficiency and automation, the software provides comprehensive functionality that benefits insurers across various sectors. Honored with the XCelent Award...

Continue Reading
Opportunity for LAZR Investors: Join the Class Action Today

Updated Category News Views 175

Investing in Luminar Technologies: What You Need to Know For those invested in Luminar Technologies, Inc. (NASDAQ: LAZR), important news is unfolding regarding a recent class-action lawsuit that has potential implications for shareholders. The Rosen Law Firm, a reputable entity in securities law, has issued a reminder for investors who purchased Luminar securities during...

Continue Reading
Celebrating HVAC Techs: Behind-the-Scenes Heroes

Updated Category News Views 8

Recognizing the Unsung Heroes of Home Comfort Let's face it, HVAC techs don't always get the recognition they deserve. On National HVAC Technician Day, June 22, Bacon Plumbing Heating Air Electric took a moment to shine a light on those skilled folks keeping homes comfy year-round across the Dallas-Fort Worth Metroplex. You know, the folks who swoop in just in time during...

Continue Reading